These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29286985)

  • 1. Trends in oral and vaginally administered estrogen use among US women 50 years of age or older with commercial health insurance.
    Weissfeld JL; Liu W; Woods C; Zhang R; Li J; van der Vlugt TH; Slaughter SR
    Menopause; 2018 Jun; 25(6):611-614. PubMed ID: 29286985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A decade of postmenopausal hormone therapy prescribing in the United States: long-term effects of the Women's Health Initiative.
    Steinkellner AR; Denison SE; Eldridge SL; Lenzi LL; Chen W; Bowlin SJ
    Menopause; 2012 Jun; 19(6):616-21. PubMed ID: 22648302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of postmenopausal hormone therapy between 2002 and 2009.
    Ettinger B; Wang SM; Leslie RS; Patel BV; Boulware MJ; Mann ME; McBride M
    Menopause; 2012 Jun; 19(6):610-5. PubMed ID: 22207318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of menopausal hormones in the United States, 1992 through June, 2003.
    Wysowski DK; Governale LA
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):171-6. PubMed ID: 15386701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy.
    Simon JA; Laliberté F; Duh MS; Pilon D; Kahler KH; Nyirady J; Davis PJ; Lefebvre P
    Menopause; 2016 Jun; 23(6):600-10. PubMed ID: 26953655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From systemic hormone therapy to vaginal estrogen - a nationwide register study in Finland, 2003-2012.
    Holm E; Aaltonen K; Heikkinen AM; Tiihonen M
    Maturitas; 2014 Aug; 78(4):293-7. PubMed ID: 24934885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of postmenopausal hormone therapy between 2002 and 2009.
    Ettinger B; Wang SM; Leslie RS; Patel BV; Boulware MJ; Mann ME; McBride M
    Menopause; 2018 Nov; 25(11):1306-1312. PubMed ID: 30358727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.
    Pinkerton JV; Santoro N
    Menopause; 2015 Sep; 22(9):926-36. PubMed ID: 25692877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities.
    Derby CA; Hume AL; Barbour MM; McPhillips JB; Lasater TM; Carleton RA
    Am J Epidemiol; 1993 May; 137(10):1125-35. PubMed ID: 8317442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal estrogen use and effects on quality of life and urogenital morbidity in postmenopausal women after publication of the Women's Health Initiative in New York City.
    Setty P; Rekedal L; Warren MP
    Menopause; 2016 Jan; 23(1):7-10. PubMed ID: 26263282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of transdermal nonpatch estrogen therapy for the management of menopausal symptoms.
    Carroll N
    J Womens Health (Larchmt); 2010 Jan; 19(1):47-55. PubMed ID: 20088658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
    Meaidi A; Goukasian I; Lidegaard O
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.